News & Updates

Reduced tacrolimus dose needed when used with fluconazole in renal transplant patients

09 Nov 2022

Renal transplant patients need a 20-percent reduction in tacrolimus (TAC) total daily dose (TDD) when used in tandem with low-dose fluconazole (LDF) to achieve therapeutic levels, suggests a recent study.

Reduced tacrolimus dose needed when used with fluconazole in renal transplant patients

09 Nov 2022

Outpatient management, skipping redundant tests help cut cost of treating SSTIs

09 Nov 2022

Inpatient management of skin and soft tissue infections (SSTIs) often uses substantial healthcare resources, but identification of outpatient candidates and avoidance of tests with low diagnostic capacity can reduce the economic burden of SSTIs, suggests a study.

Outpatient management, skipping redundant tests help cut cost of treating SSTIs

09 Nov 2022

Cabotegravir-rilpivirine regimen feasible in hospitals

09 Nov 2022 by

A once-every-two-months (Q2M) dosing regimen of cabotegravir with rilpivirine long-acting (CAB+RPV LA) can be easily implemented in hospitals and draws high levels of acceptability, appropriateness, and feasibility feedback from healthcare staff, according to a study presented at the recently concluded 2022 HIV Glasgow Conference.

Cabotegravir-rilpivirine regimen feasible in hospitals

09 Nov 2022

TIL therapy improves PFS in patients with advanced melanoma

09 Nov 2022 by

Tumour-infiltrating lymphocyte therapy significantly improved progression-free survival (PFS) in patients with advanced melanoma compared with standard-of-care treatment with ipilimumab, according to the M14TIL trial presented at ESMO 2022.

TIL therapy improves PFS in patients with advanced melanoma

09 Nov 2022

Atezolizumab bests chemo in advanced NSCLC

09 Nov 2022 by

First-line immunotherapy treatment with atezolizumab – a PD-L1 inhibitor – offers a survival advantage over single-agent chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) who are ineligible for platinum doublets in the phase III IPSOS trial.

Atezolizumab bests chemo in advanced NSCLC

09 Nov 2022

Is vonoprazan an alternative to pantoprazole in preventing post-EVL ulcers, bleeding?

08 Nov 2022 by

Vonoprazan may be as effective as pantoprazole in reducing the risk of ulcers or bleeding following endoscopic variceal ligation (EVL) in patients with portal hypertension, according to a small study from Egypt presented at the United European Gastroenterology Week (UEG 2022).

Is vonoprazan an alternative to pantoprazole in preventing post-EVL ulcers, bleeding?

08 Nov 2022

Ticagrelor–aspirin more effective in patients with normal vs impaired renal function

08 Nov 2022

Patients with normal, instead of impaired, renal function tend to benefit more from the combination therapy ticagrelor plus aspirin than clopidogrel plus aspirin, reveals a study.

Ticagrelor–aspirin more effective in patients with normal vs impaired renal function

08 Nov 2022

EDS device with fluticasone cuts CRS exacerbations

08 Nov 2022 by

The use of an exhalation delivery system with fluticasone (EDS-FLU) significantly reduces acute exacerbations of chronic rhinosinusitis (CRS), which may help drive down the need for antibiotics and prevent antibiotic resistance, in the ReOpen1 and 2 randomized controlled trials.

EDS device with fluticasone cuts CRS exacerbations

08 Nov 2022

Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV

07 Nov 2022 by

For pregnant women with HIV who are receiving dolutegravir (DTG)-based therapies, the two-drug regimen works just as well as three-drug regimens at keeping the viral load to "undetectable" levels without exerting serious adverse effects on neonatal outcomes, according to a study presented at HIV Glasgow 2022 Congress.

Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV

07 Nov 2022

Apixaban prevents gastrointestinal bleeding in patients with atrial fibrillation

07 Nov 2022

Use of apixaban in patients with atrial fibrillation (AF) helps reduce the risk of gastrointestinal bleeding (GIB), results of a study have shown.

Apixaban prevents gastrointestinal bleeding in patients with atrial fibrillation

07 Nov 2022

News & Updates

Filter by Specialty:

Specialty:

Reduced tacrolimus dose needed when used with fluconazole in renal transplant patients

Reduced tacrolimus dose needed when used with fluconazole in renal transplant patients

Outpatient management, skipping redundant tests help cut cost of treating SSTIs

Outpatient management, skipping redundant tests help cut cost of treating SSTIs

Cabotegravir-rilpivirine regimen feasible in hospitals

Cabotegravir-rilpivirine regimen feasible in hospitals

TIL therapy improves PFS in patients with advanced melanoma

TIL therapy improves PFS in patients with advanced melanoma

Atezolizumab bests chemo in advanced NSCLC

Atezolizumab bests chemo in advanced NSCLC

Is vonoprazan an alternative to pantoprazole in preventing post-EVL ulcers, bleeding?

Is vonoprazan an alternative to pantoprazole in preventing post-EVL ulcers, bleeding?

Ticagrelor–aspirin more effective in patients with normal vs impaired renal function

Ticagrelor–aspirin more effective in patients with normal vs impaired renal function

EDS device with fluticasone cuts CRS exacerbations

EDS device with fluticasone cuts CRS exacerbations

Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV

Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV

Apixaban prevents gastrointestinal bleeding in patients with atrial fibrillation

Apixaban prevents gastrointestinal bleeding in patients with atrial fibrillation